Delivery Order SPE2DB20D1109-SPE2DB25FP12N

Award Date 5/23/25
Potential Completion Date 5/27/25
Potential Value $74K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of the pharmaceutical product Biktarvy 50-200-25 mg tablet to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $12,109.08 and a period of performance that ends on June 11, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is registered in the System for Award Management (SAM.gov). The contract is a delivery order with a firm...
This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablet, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $49,102.44 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 26, 2023. The contract is not associated with a...
This federal contract award, valued at $6,434.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Biktarvy 50-200-25 mg tablet, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a completion date of November 21, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $38,888.67 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Biktarvy 50-200-25 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,022.25 delivery order contract is for the supply of Biktarvy 50-200-25 mg tablets, a prescription medication, with a period of performance through April 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Biktarvy 50-200-25 mg tablets. The contract has a ceiling value of $13,311.71 and an ultimate completion date of October 30, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Biktarvy 50-200-25 mg tablets, a specialty medication. The contract has a ceiling value of $9,448.86 and runs through December 12, 2023. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $77,011.78, is for the delivery of Biktarvy 50-200-25 mg tablet medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 1, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,669.86 contract is for the delivery of Biktarvy 50-200-25 mg tablets. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,209.45, is for the delivery of Biktarvy 50-200-25 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB25FP12N
    Delivery Order

This federal contract award is for the pharmaceutical product Biktarvy 50-200-25 mg tablet, with a ceiling value of $74,022.59. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order, with a firm fixed-price pricing type, and does not have a set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026 to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 8/22/25, 9:51 AM